Outcomes in reactive arthritis

Psoriatic and Reactive Arthritis: A Companion to Rheumatology

Volumn , Issue , 2007, Pages 200-208

  Keat, Andrew ^a   Hamdulay, Shahir ^b  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959227858     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03622-1.50030-6     Document Type: Chapter

References (78)

1. Paronen I. Reiter's disease: A study of 344 cases observed in Finland. Acta Med Scand (Suppl) 1948, 212:1-112.
2. Sairainen E, Paronen I, Mahohen H. Reiter's syndrome: A followup study. Acta Med Scand 1969, 115:57-63.
3. Vermeulen C, Lemaire V, Liote F. Joint manifestations related to Clostridium difficile. Presse Med 2000, 29:476-481.
4. Loffler HA, Pron B, Mouy R, et al. Clostridium difficile-associated reactive arthritis in two children. Joint Bone Spine 2004, 71:60-62.
5. Ducroix-Roubertou S, Genet C, Rogez JP, et al. Reactive arthritis due to Clostridium difficile. Med Mal Infect 2005, 35:419-421.
6. Guillemain P, Gerster JC Reactive arthritis induced by Clostridium difficile enteritis. Schweitz Rundsch Med Prax 2005, 94:471-474.
7. Noer HR An "experimental" epidemic of Reiter's syndrome. JAMA 1966, 198:693-698.
8. Calin A, Fries JS An "experimental" epidemic of rheumatoid arthritis revisited: Follow-up evidence on genetic and environmental factors. Ann Intern Med 1976, 84:564-566.
9. Simon DG, Kaslow RA, Rosenbaum J, et al. Reiter's syndrome following epidemic shigellosis. J Rheumatol 1981, 8:969-973.
10. Kaslow RA, Ryder RW, Calin A. Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol 1979, 6:562-566.
11. Finch M, Rodey G, Lawrence D, Blake P. Epidemic Reiter's syndrome following an outbreak of shigellosis. Eur J Epidemiol 1986, 1:26-30.
12. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis attributable to shigella infection: A clinical and epidemiological nationwide study. Ann Rheum Dis 2005, 64:594-598.
13. Hakansson U, Low B, Eitrem R, Winblad S. HL-A 27 and reactive arthritis in an outbreak of salmonellosis. Tissue Antigens 1975, 6:366-367.
14. Inman RD, Johnston OAE, Hodge M, et al. Post-dysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988, 31:1377-1383.
15. Locht H, Kihlstrom E, Lindstrom FD Reactive arthritis after salmonella among medical doctors-Study of an outbreak. J Rheumatol 1993, 20:845-848.
16. Mattila L, Leirisalo-Repo M, Koskimies S, et al. Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 1994, 33:1136-1141.
17. Thomson GT, De Rubeis DA, Hodge MA, et al. Post-salmonella reactive arthritis: Late clinical sequelae in a point source cohort. Am J Med 1995, 98:13-21.
18. Rudwaleit M, Richter S, Braun J, Zieper J. Low incidence of reactive arthritis in children following a salmonella outbreak. Ann Rheum Dis 2001, 60:1055-1057.
19. Dworkin MS, Shoemaker PC, Goldoft MJ, Kobayashi JM Reactive arthritis and Reiter's syndrome following an outbreak of gastroenteritis caused by Salmonella enteritidis. Clin Infect Dis 2001, 33:1010-1014.
20. Locht H, Molback F, Krogfelt KA High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis. J Rheumatol 2002, 29:767-771.
21. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis 2002, 61:264-266.
22. Lee AT, Hall RG, Pile KD Reactive joint symptoms following an outbreak of Salmonella typhimurium phage type 135a. J Rheumatol 2005, 32:524-527.
23. Eastmond CJ, Rennie JA, Reid TM An outbreak of Campylobacter enteritis-A rheumatological follow-up survey. J Rheumatol 1983, 10:107-108.
24. Bremell T, Bjelle A, Svedhen A. Rheumatic symptoms following an outbreak of campylobacter enteritis: A 5-year follow-up. Ann Rheum Dis 1991, 50:934-938.
25. Melby KK, Svendby JG, Eggebo T, et al. Outbreak of campylobacter infection in a sub-arctic community. Eur J Clin Microbiol Infect Dis 2000, 19:542-544.
26. Hannu T, Mattila L, Rautelin H, et al. Campylobacter-triggered reactive arthritis: A population-based study. Rheumatology (Oxford) 2002, 41:312-318.
27. Hannu T, Kauppi M, Tuomala M, et al. Reactive arthritis following an outbreak of Campylobacter jejuni infection. J Rheumatol 2004, 31:528-530.
28. Press N, Fyfe M, Bowie W, Kelly M. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype 1B. Scand J Infect Dis 2001, 33:523-526.
29. Hannu T, Mattila L, Nuorti JP, et al. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3infection. Ann Rheum Dis 2003, 62:866-869.
30. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983, 309:1606-1615.
31. Keat AC, Maini RN, Pegrum GD, Scott JT The clinical features and HLA associations of reactive arthritis associated with nongonococcal urethritis. Q J Med 1979, 48:323-342.
32. Csonka GW The course of Reiter's syndrome. Br Med J 1958, 1:1088-1090.
33. Keat AC, Maini RN, Nkwazi GC, et al. Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. Br Med J 1978, 1:605-607.
34. Szanto E, Hagenfeldt K. Sacro-iliitis and salpingitis: Quantitative 99mTc pertechnetate scanning in the study of sacro-iliitis in women. Scand J Rheumatol 1979, 8:129-135.
35. Hughes RA, Keat AC Reiter's syndrome and reactive arthritis: A current view. Semin Arthritis Rheum 1994, 24:190-210.
36. Colmegna I, Cuchacovich R, Espinosa LR HLA-B27-associated reactive arthritis: Pathogenetic and clinical considerations. Clin Microbiol Rev 2004, 17:348-369.
37. Wollenhaupt J, Schneider C, Zeidler H, et al. Clinical and serological characterization of Chlamydia-induced arthritis. Dtsch Med Wochenschr 1989, 114:1949-1954.
38. Kousa M, Saikku P, Witmand S, Lassus A. Frequent association of chlamydial infection with Reiter's syndrome. Sex Transm Dis 1978, 5:57-61.
39. Keat AC, Thomas BJ, Taylor-Robinson D, et al. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980, 39:431-437.
40. Silveira LH, Gutierrez F, Scopelitis E, et al. Chlamydia-induced reactive arthritis. Rheum Dis Clin North Am 1993, 19:351-362.
41. Martin DH, Bowie WR Urethritis in males. Sexually Transmitted Diseases 1999, 833-845. McGraw-Hill, New York. 3rd ed. K.K. Holmes, P.F. Sparling, P.-A. Mardh (Eds.).
42. Middleton PJ, Highton TC Failure to show mycoplasmas and cytopathic virus in rheumatoid arthritis. Ann Rheum Dis 1975, 34:369-372.
43. Horowitz S, Horowitz J, Taylor-Robinson D, et al. Ureaplasma urealyticum in Reiter's syndrome. J Rheumatol 1994, 21:877-882.
44. Scheverbaeke T, Gilroy CB, Bébéar C, et al. Mycoplasma fermentans but not M. penetrans detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol 1996, 49:824-828.
45. Gilroy CB, Keat A, Taylor-Robinson D. The prevalence of Mycoplasma fermentans in patients with inflammatory arthritides. Rheumatology (Oxford) 2001, 40:1355-1358.
46. Brewerton DA, Caffrey M, Nicholls A, et al. Reiter's disease and HLA-27. Lancet 1973, 2:996-998.
47. Reveille JD, Arnett FC Spondyloarthritis: Update on pathogenesis and management. Am J Med 2005, 118:592-603.
48. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthopathies. Rheum Dis Clin North Am 1998, 24:737-751.
49. Glennas A, Kvien TK, Melby K, et al. Reactive arthritis: A favourable 2-year course and outcome independent of triggering agent and HLA-B27. J Rheumatol 1994, 21:2274-2278.
50. Mattila L, Leirisalo-Repo M, Pelkenen P, et al. Reactive arthritis following an outbreak of Salmonella bovismorbisicans infection. J Infect 1998, 36:289-295.
51. Leirisalo-Repo M, Helenius P, Hannu T, et al. Long-term prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997, 56:516-520.
52. Leirisalo-Repo M. Prognosis, course of disease and treatment of the spondyloarthopathies. Rheum Dis Clin North Am 1998, 24:737-751.
53. Amor B, Santos RS, Nahal R, et al. Predictive factors for the long-term outcome of spondyloarthopathies. J Rheumatol 1994, 21:1883-1887.
54. Good AE Reiter's syndrome: Long-term follow-up in the relation to development of ankylosing spondylitis. Ann Rheum Dis 1979, 38(Suppl):39.
55. Van der Linden SM, Valkenburg HA, de Jong BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984, 27:241-249.
56. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthopathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995, 22:2279-2284.
57. Fox A, Calin A, Gerber RC, Gibson D. The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Intern Med 1979, 91:190-193.
58. Penttinen MA, Ekman P, Granfors K. Non-antigen presenting effects of HLA-B27. Curr Mol Med 2004, 4:41-49.
59. Inman RD, Payne U. Determinants of synoviocyte clearance of arthritogenic bacteria. J Rheumatol 2003, 30:1291-1297.
60. Popert AJ, Gill SM, Laird AJ A prospective study of Reiter's syndrome. An interim report on the first 82 cases. Br J Vener Dis 1964, 40:160-165.
61. Fryden A, Bengtsson A, Foberg U, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: Clinical and serological study. BMJ 1990, 301:1299-1302.
62. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992, 35:190-194.
63. Panayi GS, Clark B. Minocycline in the treatment of patients with Reiter's syndrome. Clin Exp Rheumatol 1989, 7:100-101.
64. Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991, 34:6-14.
65. Toivanen A, Yli-Kerrtula T, Luukainen R, et al. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993, 11:301-307.
66. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum 1999, 42:1386-1396.
67. Hoogkamp-Korstanje JA, Moesker H, Bruyn GA Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis 2000, 59:914-917.
68. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000, 59:565-570.
69. Smieja M, MacPherson DW, Kean W, et al. Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis. Ann Rheum Dis 2001, 60:1088-1094.
70. Kvien TK, Gaston JSH, Bardin T, et al. Three month treatment of reactive arthritis with azithromycin: A EULAR double blind, placebo controlled study. Ann Rheum Dis 2004, 63:1113-1119.
71. Wakefield D, McCluskey P, Verma M, et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999, 42:1894-1897.
72. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis 2003, 62:655-658.
73. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 2003, 62:880-884.
74. Carlin EM, Keat AC European guideline for the management of sexually acquired reactive arthritis. Int J STD AIDS 2001, 12(Suppl 3):94-102.
75. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs cooperative study. Arthritis Rheum 1996, 39:2021-2027.
76. Charlotte E, Hansen TM, Andersen LS, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997, 56:32-36.
77. Anandarajah A, Ritchlin CT Treatment update on spondyloarthropathy. Curr Opin Rheumatol 2005, 17:247-256.
78. Oili KS, Niinisalo H, Korpilahde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol 2003, 32:122-124.